MS
Morgan Stanley
$213.79
▲ +0.83%
+$1.76
NYSE · Financial Services · Capital Markets
Morgan Stanley
MS · NYSE · Financial Services · Capital Markets
$213.79
▲ +0.83% · +$1.76 today
fundamentals64.1 /100 vs peers
solid
Revenue growth (TTM)16.3
solid pace
EPS growth (TTM)29.4
strong pace
EPS forecast (5Y)11.3
average pace
EPS next year7.8
solid pace
EPS growth (Q/Q)32.1
strong pace
Compared against sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| MSMorgan Stanley | $337.20B | 19.3 | +14.2% | 64 |
| SCHWThe Charles Schwab Corporation | $157.69B | 18.0 | +21.2% | 84 |
| XBISPDR S&P Biotech ETF | $0 | 0.0 | — | 83 |
| NUNu Holdings Ltd. | $63.47B | 20.1 | — | 81 |
| ENVAEnova International, Inc. | $4.20B | 13.7 | +17.5% | 79 |
